Over 4 mln COVID-19 vaccine doses from China's CNBG administered in emergency use

More than 4 million COVID-19 vaccine doses from China National Biotec Group (CNBG) have been administered as of Jan. 4 via China's emergency use program, the company's parent firm said late on Thursday. Two vaccines respectively from two institutes owned by CNBG, a unit of state-backed China National Pharmaceutical Group (Sinopharm), are included in China's emergency vaccination scheme, which was officially started in July targeting specific groups of people facing a high infection risk.

Reuters | Updated: 09-01-2021 06:30 IST | Created: 09-01-2021 06:30 IST
Over 4 mln COVID-19 vaccine doses from China's CNBG administered in emergency use

More than 4 million COVID-19 vaccine doses from China National Biotec Group (CNBG) have been administered as of Jan. 4 via China's emergency use program, the company's parent firm said late on Thursday.

Two vaccines respectively from two institutes owned by CNBG, a unit of state-backed China National Pharmaceutical Group (Sinopharm), are included in China's emergency vaccination scheme, which was officially started in July targeting specific groups of people facing a high infection risk. "No serious adverse reaction was reported in large-scale emergency use of Sinopharm's COVID-19 vaccines," Sinopharm said on Chinese social media WeChat.

A total of 72,000 people have been overseas after receiving China's emergency jabs, including around 40% of more than 5,000 staffers on one Chinese firm's Pakistan-based project, Sinopharm said. None of the vaccinated diplomats, international organization representatives or employees at Chinese firms, who went to countries of high virus risk, contracted the COVID-19 disease caused by the new coronavirus, despite their close contact with infected locals, Sinopharm said.

The firm did not break down the number of doses for each of the two vaccines used in the emergency program. Aside from CNBG's two vaccines, China's emergency use program also includes a potential shot from Sinovac Biotech . A fourth candidate from CanSino Biologics was approved for use in Chinese military personnel.

The vaccine from CNBG's unit Beijing Institute of Biological Products was approved in China for broader use among the general public last year. The two-dose regimen is 79.34% effective against the disease, according to interim analysis from late-stage clinical trials overseas. Although the CNBG vaccine's protection rate is lower than the more than 90% efficacy of vaccines from Moderna Inc or Pfizer Inc and its partner BioNTech SE, it can be transported and stored at less demanding temperatures.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

Brazil registers over 1,300 COVID-19 deaths for fifth straight day

Brazil registered 1,386 COVID-19 deaths on Saturday and 61,602 additional cases, according to data released by the nations Health Ministry.The South American country has suffered an enduring second wave since November, and infection rates h...

Rugby-Refereeing decisions spark furious debate after Wales win

Englands coach and captain remained tight-lipped over the controversial decisions that gave Wales two early tries in Saturdays 40-24 Six Nations victory in Cardiff on Saturday but there was no shortage of debate among pundits.Wales scored f...

REUTERS NEWS SCHEDULE 10 p.m. GMT/6:00 a.m. SGT

Saudi Crown Prince Mohammed bin Salman may have been spared direct punishment after a U.S. intelligence report implicated him in the killing of dissident journalist Jamal Khashoggi, but he has not emerged unscathed. NIGERIA-SECURITY Nigeria...

Myanmar's U.N. ambassador vows to fight after junta fired him

Myanmars United Nations envoy in New York vowed to fight on Saturday after the junta fired him for urging countries to use any means necessary to reverse a Feb. 1 coup that ousted the nations elected leader Aung San Suu Kyi.I decided to fig...

Give Feedback